ORIGINAL STUDIES |
|
Semashko A.S., Galushko E.A., Lila A.M.
Diagnosis of anemic syndrome in patients with active rheumatoid arthritis
|
8-15 |
|
Yuzhakova E.V., Smirnova E.N.
Experience of dapagliflozin use in elderly female patients with hyperactive urinary bladder
|
16-20 |
|
Kobzeva N.D., Demidova A.A., Shlyk S.V., Martynov A.I., Shlyk I.F.
Estimation of the risk of cardiovascular events and adverse outcomes in patients with peripheral atherosclerosis
|
21-29 |
|
Salyamova L.I., Kvasova O.G., Babkina I.A., Rymar V.V.
Life quality and prognosis of patients with adverse post-infarction left ventricle remodeling
|
30-38 |
|
Safronenko V.A., Chesnikova A.I.
Gender peculiarities of clinical manifestations in patients with arterial hypertension and chronic heart failure in combination with senile asthenia syndrome
|
40-52 |
REVIEWS |
|
Egorova O.N., Tarasova G.M., Lila A.M.
Panniculitis: Aspects of diagnosis
|
53-62 |
|
Eliseev M.S.
What we know about gout today
|
63-73 |
|
Dobrovolskaya O.V., Feklistov A.Yu., Toroptsova N.V.
Sarcopenia: Aspects of diagnosis and prevention
|
74-84 |
|
Makarov M.A., Roskidailo A.A.
Modern methods of surgical treatment of patients with rheumatic diseases
|
85-91 |
|
Yakovenko E.P., Strokova T.V., Yakovenko A.V., Kuvaev R.O., Ivanov A.N., Bagaeva M.E.
Clinical estimation of liver functional tests
|
92-103 |
|
Budnevsky A.V., Gubanov D.S., Bavykina I.A., Makeeva A.V., Budnevskaya S.A., Chernik T.A.
Comorbidity of chronic obstructive pulmonary disease and anemia: Clinical course peculiarities, diagnosis, therapy
|
104-111 |
GUIDELINES FOR PRACTITIONERS |
|
Kostenko D.Yu., Rogachikov Yu.E., Kramareva O.S., Luchinin M.S.
Case of comorbid pathology: exacerbation of gastric ulcer in a patient with type A hemophilia and chronic viral hepatitis C
|
112-117 |
LECTURES & REPORTS |
|
Aseeva E.A., Solovyov S.K., Lila A.M.
Systemic lupus erythematosus in therapist’s practice
|
118-125 |
|
Beketova T.V.
ANCA-associated systemic vasculitis: Aspects of diagnosis
|
126-136 |
|
Karateev A.E.
Nonsteroidal anti-inflammatory drugs in therapeutical practice
|
138-148 |
Guideline for practitioners |
|
Martynov A.I., Baranov I.I., Orlova S.V., Akarachkova E.S., Gromova O.A., Malyavin A.G., Nechaeva G.I., Nikolaev N.A., Viktorova I.A., Druk I.V., Loginova E.N., Nadey E.V.
Resolution of the Expert council “Magnesium deficiency”
|
149-158 |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
|
Kasimova A.R., Kolbin A.S.
Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients
|
160-167 |
|
Golovatyuk A.O., Poluektov M.G.
Disorders of autonomic nervous system in clinical practice
|
168-174 |
Activities of RNMOT |
|
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (January – February 2024)
|
175-179 |
JUBILEE |
|
To the anniversary of professor Vyacheslav Mikhailovich Provotorov
|
180 |
Русский
